Search research articles
Contact Us
Filters
Showing results (21-30 of 161) with videos related to
Page
of 17
Sort By:
International Journal of Hygiene and Environmental Health
|
December 24, 2005
Environmental exposure to residential pesticides, chemicals, dusts, fumes, and metals, and risk of childhood germ cell tumors
Zhi Chen, Leslie Robison, Roger Giller, et al.
Pediatric Blood & Cancer
|
August 3, 2007
Phase 2 study of docetaxel in the treatment of childhood refractory acute leukemias: a Children's Oncology Group report
Janet L Franklin, Nita L Seibel, Mark Krailo, et al.
Pediatric Blood & Cancer
|
August 20, 2013
High-BMI at diagnosis is associated with inferior survival in patients with osteosarcoma: a report from the Children's Oncology Group
Sadaf Altaf, Felicity Enders, Elysia Jeavons, et al.
Pediatric Blood & Cancer
|
March 16, 2026
Second Malignancies in Children and Adolescents With Extracranial Germ Cell Tumors: A Report From the Malignant Germ Cell Tumor International Consortium
Priya Mahajan, Mark Krailo, Negar Fallahazad, et al.
Pediatric Blood & Cancer
|
July 10, 2009
Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group
Rebecka L Meyers, Jon R Rowland, Mark Krailo, et al.
Pediatric Blood & Cancer
|
July 25, 2015
Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group
AeRang Kim, Brigitte C Widemann, Mark Krailo, et al.
Pharmaceutical Statistics
|
June 26, 2019
Improvements to the Escalation with Overdose Control design and a comparison with the restricted Continual Reassessment Method
Lingyun Ji, Juan Pablo Lewinger, Mark Krailo, et al.
Pediatric Blood & Cancer
|
September 13, 2011
Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: a Children's Oncology Group trial (P9962)
Samara L Poplack Potter, Stacey Berg, Ashish Mark Ingle, et al.
Neuro-Oncology
|
April 10, 2015
A pilot study using carboplatin, vincristine, and temozolomide in children with progressive/symptomatic low-grade glioma: a Children's Oncology Group study†
Murali Chintagumpala, Sandrah P Eckel, Mark Krailo, et al.
Pediatric Blood & Cancer
|
July 7, 2023
Reevaluation of sodium thiosulfate otoprotection using the consensus International Society of Paediatric Oncology Ototoxicity Scale: A report from the Children's Oncology Group study ACCL0431
Etan Orgel, Kristin R Knight, Doojduen Villaluna, et al.
Page
of 17
Search research articles
Search
Showing results (21-30 of 161) with videos related to
Sort By:
Page
of 17
International Journal of Hygiene and Environmental Health
|
December 24, 2005
Environmental exposure to residential pesticides, chemicals, dusts, fumes, and metals, and risk of childhood germ cell tumors
Zhi Chen, Leslie Robison, Roger Giller, et al.
Pediatric Blood & Cancer
|
August 3, 2007
Phase 2 study of docetaxel in the treatment of childhood refractory acute leukemias: a Children's Oncology Group report
Janet L Franklin, Nita L Seibel, Mark Krailo, et al.
Pediatric Blood & Cancer
|
August 20, 2013
High-BMI at diagnosis is associated with inferior survival in patients with osteosarcoma: a report from the Children's Oncology Group
Sadaf Altaf, Felicity Enders, Elysia Jeavons, et al.
Pediatric Blood & Cancer
|
March 16, 2026
Second Malignancies in Children and Adolescents With Extracranial Germ Cell Tumors: A Report From the Malignant Germ Cell Tumor International Consortium
Priya Mahajan, Mark Krailo, Negar Fallahazad, et al.
Pediatric Blood & Cancer
|
July 10, 2009
Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group
Rebecka L Meyers, Jon R Rowland, Mark Krailo, et al.
Pediatric Blood & Cancer
|
July 25, 2015
Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group
AeRang Kim, Brigitte C Widemann, Mark Krailo, et al.
Pharmaceutical Statistics
|
June 26, 2019
Improvements to the Escalation with Overdose Control design and a comparison with the restricted Continual Reassessment Method
Lingyun Ji, Juan Pablo Lewinger, Mark Krailo, et al.
Pediatric Blood & Cancer
|
September 13, 2011
Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: a Children's Oncology Group trial (P9962)
Samara L Poplack Potter, Stacey Berg, Ashish Mark Ingle, et al.
Neuro-Oncology
|
April 10, 2015
A pilot study using carboplatin, vincristine, and temozolomide in children with progressive/symptomatic low-grade glioma: a Children's Oncology Group study†
Murali Chintagumpala, Sandrah P Eckel, Mark Krailo, et al.
Pediatric Blood & Cancer
|
July 7, 2023
Reevaluation of sodium thiosulfate otoprotection using the consensus International Society of Paediatric Oncology Ototoxicity Scale: A report from the Children's Oncology Group study ACCL0431
Etan Orgel, Kristin R Knight, Doojduen Villaluna, et al.
Page
of 17